AKT1 and cancer: Consistent with this notion, we found that the inhibition of Akt activation using LY294002 or the Akt inhibitor IV or the knockdown of Akt expression suppressed the p53‐induced increase in ROS levels and SA‐β‐gal activity in both EJ and H1299 cancer cells.